A recent study identified that retinoic acid treatment disrupts the adrenergic CRC in MYCN-amplified cell line and reprograms it into a “retino-sympathetic” CRC, resulting in rapid down-regulation of MYCN expression coupled with the induction of cell differentiation and proliferative arrest (Zimmerman et al., 2021). This evidence concerns the gene MYCN and colorectal carcinoma.